We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$40.9M
Cap. Flow
+$30.7M
Cap. Flow %
14.18%
Top 10 Hldgs %
40.9%
Holding
110
New
40
Increased
20
Reduced
11
Closed
36

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.41M
2
BIIB icon
Biogen
BIIB
+$4.44M
3
CI icon
Cigna
CI
+$3.91M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.61M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$3.18M

Top Sells

Rank Stock Value
1
ARTC
ARTHROCARE CORP
ARTC
+$3.56M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$3.4M
3
GILD icon
Gilead Sciences
GILD
+$2.74M
4
ITMN
INTERMUNE INC
ITMN
+$2.21M
5
DXCM icon
DexCom
DXCM
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 64.65%
2 Industrials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$30.5B
$13.5M 6.22%
44,000
+14,000
+47% +$4.44M
AMGN icon
2
Amgen
AMGN
$220B
$12.8M 5.93%
104,000
+4,000
+4% +$485K
AMGN icon
3
PUT
Amgen
AMGN
$220B
$12.3M 5.7%
+100,000
New +$12.1M
MRK icon
4
Merck
MRK
$317B
$11.6M 5.38%
214,840
+31,440
+17% +$1.63M
CI icon
5
Cigna
CI
$71.5B
$8.16M 3.77%
97,500
+47,500
+95% +$3.91M
ZBH icon
6
Zimmer Biomet
ZBH
$19B
$8.04M 3.72%
87,550
+5,150
+6% +$475K
MDT icon
7
Medtronic
MDT
$110B
$6.77M 3.13%
+110,000
New +$6.41M
VTRS icon
8
Viatris
VTRS
$20.6B
$5.49M 2.54%
112,500
-2,500
-2% -$121K
JNJ icon
9
CALL
Johnson & Johnson
JNJ
$621B
$4.91M 2.27%
+50,000
New +$4.64M
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.84M 2.24%
+320,000
New +$3.61M
TRNX
11
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$4.78M 2.21%
225,000
+25,000
+13% +$485K
MDT icon
12
CALL
Medtronic
MDT
$110B
$4.62M 2.13%
+75,000
New +$4.37M
AERI
13
DELISTED
Aerie Pharmaceuticals
AERI
$4.45M 2.06%
210,000
+97,500
+87% +$1.97M
ALKS icon
14
Alkermes
ALKS
$8.32B
$4.41M 2.04%
100,000
+25,000
+33% +$1.19M
NVDQ
15
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.9M 1.8%
175,000
+90,000
+106% +$1.79M
IPXL
16
DELISTED
Impax Laboratories, Inc.
IPXL
$3.83M 1.77%
145,000
+95,000
+190% +$2.37M
LLY icon
17
CALL
Eli Lilly
LLY
$1.04T
$3.83M 1.77%
+65,000
New +$3.63M
CLDX icon
18
Celldex Therapeutics
CLDX
$3.22B
$3.8M 1.76%
14,333
+1,000
+8% +$383K
BAX icon
19
PUT
Baxter International
BAX
$14.1B
$3.68M 1.7%
+92,050
New +$3.44M
PBYI icon
20
Puma Biotechnology
PBYI
$407M
$3.65M 1.69%
35,000
+10,000
+40% +$1.18M
GILD icon
21
Gilead Sciences
GILD
$164B
$3.54M 1.64%
50,000
-35,000
-41% -$2.74M
CYTK icon
22
CALL
Cytokinetics
CYTK
$10.7B
$3.43M 1.59%
+361,500
New +$3.27M
LGND icon
23
Ligand Pharmaceuticals
LGND
$6.06B
$3.36M 1.56%
80,150
-40,075
-33% -$1.67M
MRK icon
24
CALL
Merck
MRK
$317B
$3.3M 1.53%
60,994
-70,006
-53% -$3.63M
PFE icon
25
Pfizer
PFE
$147B
$3.21M 1.48%
+105,400
New +$3.14M
1
2 3 4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2014 Portfolio in Review

As of Q1 2014, Iguana Healthcare Management held 110 positions worth $216M, up 23% from $175M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management deployed $30.7M of net new capital in Q1 2014, opening 40 new positions and adding to 20 existing holdings. Its largest new stake was Medtronic: 110,000 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 61% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.74M trimmed.

  • Iguana Healthcare Management's largest Q1 2014 buy was Medtronic: 110,000 shares worth $6.77M.
  • Iguana Healthcare Management added most to Biogen in Q1 2014, an estimated $4.44M increase.
  • Iguana Healthcare Management's biggest Q1 2014 reduction was Gilead Sciences, cutting an estimated $2.74M.
  • Iguana Healthcare Management fully exited ARTHROCARE CORP in Q1 2014, selling an estimated $3.56M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $216M portfolio in Q1 2014.
  • Iguana Healthcare Management opened 40 new positions and closed 36 in Q1 2014.
  • Iguana Healthcare Management's portfolio value rose 23% quarter-over-quarter to $216M.

Based on Iguana Healthcare Management's 13F filing for Q1 2014, filed 16 May 2014.